100 Participants Needed

Duodenoscope for Biliary Disease

NA
AF
Overseen ByAmanda F Lin
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rush University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new, single-use duodenoscope called the Exalt Model D, comparing it to the traditional reusable scope. The researchers aim to determine which scope is easier to use, has fewer side effects, and reduces infection risk during procedures for bile duct or pancreatic issues. Suitable candidates for this trial include individuals with symptoms of biliary or pancreatic duct disorders confirmed by specific imaging tests and who have not undergone certain previous procedures. As an unphased trial, participants can contribute to pioneering research that may enhance future medical procedures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this duodenoscope is safe for biliary disease?

Research has shown that the Exalt Model D, a single-use duodenoscope, is generally safe for patients. In a study with 98 participants, researchers used this device for ERCP, a procedure that examines the bile and pancreatic ducts. The study found that this single-use scope worked successfully in 91.7% of the procedures, with only one instance where the scope did not stay in place properly.

Another study demonstrated a high success rate of 98.5% when the Exalt Model D was used with another single-use scope. No major safety issues were reported, suggesting that the Exalt Model D is well-tolerated and has a low risk of complications.12345

Why are researchers excited about this trial?

Researchers are excited about the Exalt Model D duodenoscope because it offers a single-use design, which significantly reduces the risk of cross-contamination and infection associated with traditional reusable duodenoscopes. This is a big deal because standard reusable models require complex cleaning procedures that aren’t always foolproof. The Exalt Model D provides a fresh scope for each procedure, potentially improving patient safety and reducing the burden on healthcare facilities to maintain rigorous cleaning protocols.

What evidence suggests that this trial's duodenoscopes could be effective for biliary disease?

In this trial, participants will be assigned to one of two treatment arms: the Exalt Model D, a single-use scope, or a standard reusable duodenoscope for ERCP procedures. Research has shown that the Exalt Model D performs well for ERCP procedures, successfully completing the procedure in 97.2% of cases in one study. Another study found it to be a practical and cost-effective alternative to reusable scopes, particularly in reducing infection risks. Although a small number of users experienced difficulty with positioning, this issue also occurred with reusable scopes. Overall, the Exalt Model D is a reliable choice for procedures related to bile duct diseases.46789

Who Is on the Research Team?

NA

Neal A Mehta, MD

Principal Investigator

Rush University Medical Center

Are You a Good Fit for This Trial?

This trial is for individuals with gallbladder disorders, pancreatic duct dysfunction, or biliary disease. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions relevant to the study.

Inclusion Criteria

My body's natural duct openings are intact.

Exclusion Criteria

Pregnancy
Patients with percutaneous transhepatic biliary drainage
Inability to provide informed consent
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo ERCP using either the Exalt Model D single-use duodenoscope or the standard reusable duodenoscope

1 day
1 visit (in-person)

Follow-up

Participants are monitored for adverse events and infection rates post-ERCP

7 days
1 visit (in-person), follow-up calls

What Are the Treatments Tested in This Trial?

Interventions

  • Exalt Model D
  • Reusable
Trial Overview The trial is testing a new disposable duodenoscope called Exalt Model D against traditional reusable scopes. It aims to compare their effectiveness and safety by looking at how easy they are to use, any adverse events that occur, if there's a need to switch between them (crossover events), and infection rates after procedures.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Exalt Model DExperimental Treatment1 Intervention
Group II: Standard ReusableActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+

Citations

Clinical data - EXALT™ Model D DuodenoscopeThis randomised trial of 98 patients compared the performance of the EXALT Model D Single-Use Duodenoscope with reusable duodenoscopes in patients undergoing ...
A Cost-Effectiveness Analysis of Exalt Model D Single-Use ...Single-use duodenoscopes are a viable and cost-effective strategy that should be considered for ERCP to address concerns regarding reusable duodenoscope ...
Single-Use Duodenoscopes for ERCPIn this study, ERCP was performed in 60 patients using the EXALT Model D single-use duodenoscope. Outcomes for this study included successful completion of ERCP ...
ID: 3526115 THE EXALT MODEL D SINGLE-USE ...In one patient (2.8%), failure occurred due to an unstable position; of note, the procedure remained unsuccessful after crossover to a reusable ...
Efficacy and safety of single use duodenoscopes in ...This was a single-center case control study conducted to investigate the performance and safety of a single-use duodenoscope (EXALT Model D, ...
Clinical dataThis randomized trial of 98 patients compared the performance of EXALT Model D Single-Use Duodenoscope with reusable duodenoscopes in patients undergoing ERCP.
Efficacy and safety of single use duodenoscopes in ...The primary outcome was successful ERCP completion rates. The secondary outcomes were rate of difficult biliary cannulation, incidence of crossover from SD to ...
Original Article/Biliary The outcomes and safety of patients ...Our data showed that the single-use duodenoscope combined with a single-use cholangioscope obtained excellent results in terms of technical success (98.5%), ...
Clinical Evaluation of a Single-Use Duodenoscope for ...We conducted a case-series study of the outcomes of ERCP with a single-use duodenoscope from April through May 2019 at 6 academic medical ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security